| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |